BioSpace News Archive

Bausch Health Companies Inc., Bausch + Lomb, and Eyenovia, Inc. announced that an affiliate of Bausch Health has acquired an exclusive license in the United States and Canada for the development and commercialization of an investigational microdose formulation of atropine ophthalmic solution, which is being investigated for the reduction of pediatric myopia progression, also known as nearsightedness, in children ages 3-12.

Life sciences organizations are modernizing clinical data management with Veeva, including a second top 20 pharmaceutical company

Authored by esteemed experts in immunology and leaders at the forefront of inflammasome research at University of Miami Miller School of Medicine

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that pre-clinical data on the Company’s lead product candidate BDTX-189 will be presented at the 32 nd EORTC-NCI-AACR Virtual Symposium on Molecular Targets and Cancer Therapeutics (ENA 2020) taking place October 24-25, 2020. Presentation de

Brainomix, an Oxford-based company specializing in the creation of AI-powered imaging biomarkers to enable precision medicine for better treatment decisions, today announced two new additions to its Board of Directors, with the appointment of Professor Jacqueline (“Jackie”) Hunter as Chairperson and Professor Heinz-Otto

Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for Oncology (L35396) provides coverage for Cxbladder (0012M and 0013M) for tests performed on or after July 1, 2020 that are medically necessary. This LCD coverage enables national reimbursement for Cxbladder tests performed among the approximately 62 million people who have Medicare coverage with the Centers for Medicare

TFS recently entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) to provide data management solutions across the academic research organization’s study portfolio. The partnership supports TFS’s growth strategy and aligns its clinical development services with an organization renowned for bringing

Fresenius Medical Care North America (FMCNA) , the nation’s leading renal care company, celebrates National Dialysis Technician Recognition Week by announcing a new collaboration wit

Newly disclosed data build on topline results and continue to support GB004’s differentiated approach of targeting epithelial barrier restoration in patients with ulcerative colitis - - GB004 demonstrated superior barrier protection compared to tofacitinib in pre-clinical human monolayer assay - - S HIF T-UC Phase 2 study active and screening patients for enrollment - SAN DIEGO--( BUSINESS WIRE )-- Gossamer Bio, Inc. (Nasdaq: GOSS),

Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, Daxor’s President and Chief Executive Officer, will present at the virtual 2020 MicroCap Rodeo Best Ideas Bowl on Tuesday, October 13th at 3:00 PM ET. Mr. Feldschuh will provide a company overview and discuss key highlights including new researc